This is a Post-Marketing Surveillance of GMK Sphere knee prosthesis.
Eligibility
Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* A disabled or severely disabled joint as a result of arthritis, traumatic arthritis, rheumatoid arthritis, poly-arthritis or avascular necrosis
* Patients must be between the age of 18 and 80 at the time of consent
* Listed for total knee replacement surgery.
* Patients who are willing to give informed written consent
Exclusion Criteria:
* Progressive local or systemic infection
* Muscular loss, neuromuscular disease or vascular deficiency of the affected limb, making the operation unjustifiable
* Severe instability secondary to advance destruction of condylar structures or loss of integrity of the medial or lateral ligament
* Any patient who cannot or will not provide informed consent for participation in the study
* Those whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems
* Patient whose BMI exceeds 40
* Any case not described in the inclusion criteria
Primary outcome measure(s)
Assessment of the clinical outcome following total knee replacement using the Knee Society Score. — 6 months
Trial sites (4)
Facility
City
Region
Status
AZ Maria Middelares
Ghent
Belgium
Royal London Hospital
Whitechapel
London
Royal National Orthopaedic Hospital NHS Trust
Stanmore
Middlesex
The Elective Orthopaedic Centre (EOC)
Epsom
Surrey
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.